Industry Verticals »

All Categories

Insights »

About TMR »

Photopheresis Products Market

Photopheresis Products Market (Product Type - Open System and Closed System; End User - Hospitals and Clinics; Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections, and Autoimmune Diseases) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global photopheresis products market for the historical period 2017–2018 and forecast period 2019–2027. The global photopheresis products market is driven by increase in increase in organ transplantations, increase in cutaneous T-cell lymphoma and favorable reimbursement policies.
  • According to the report, the global photopheresis products market was valued at US$ 262.4 Mn in 2018 and is anticipated to expand at a CAGR of 5.3% from 2019 to 2027

Increase in Cutaneous T-cell Lymphoma Population: Key Driver

  • Cutaneous T-cell lymphoma is a rare type of non-Hodgkin lymphoma that affects the skin. According to the Cutaneous Lymphoma Foundation, the incidence of CTL is approximately 1500 new cases per year in the U.S. and prevalence of CTL is around 16,000 to 20,000 cases. Physicians follow various therapies to treat CTL conditions.
  • However, ECP is considered the first line therapy to treat IIB and IV MF conditions and is more effective in treating sezary syndrome patients

Expensive and Long Treatment Procedure: Restraints

  • ECP therapy is reimbursed by governments; however, these are still costly even after reimbursement. ECP therapy takes longer time to treat and perform.
  • For instance, on average, it takes around two to three hours to treat various disease conditions using photopheresis medical devices
  • In the U.S., ECP therapy costs around US$ 8000 per treatment and every individual has to take the treatment for every two weeks and continue the same procedure for one year to complete the treatment.

Global Photopheresis Products Market: Competitive Landscape

  • This report profiles major players operating in the global photopheresis products market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global photopheresis products market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global photopheresis products market include
    • Macopharma,
    • Med Tech Solutions GmbH,
    • Haemonetics Corporation,
    • Fresenius Kabi AG,
    • Terumo Corporation,
    • Mallinckrodt Pharmaceuticals others among others

Global Photopheresis Products Market: Key Developments

Key players in the global photopheresis products market are engaged in regulatory approvals, launch of new products, training and development, acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global photopheresis products market. A few expansion strategies adopted by players operating in the global photopheresis products market are:

  • Recently in October 2019, Mallinckrodt plc a global biopharmaceutical company, and Terumo BCT, a global leader in blood component, announced that UVADEX (methoxsalen) has received regulatory approval in Australia by the Australian Therapeutic Goods Administration (TGA) for extracorporeal administration with the THERAKOS CELLEX Photopheresis System.   

The report on the global photopheresis products market discussed individual strategies, followed by company profiles of manufacturers of photopheresis products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global photopheresis products market.

Photopheresis Products Market -Outline

The photopheresis products market is prognosticated to observe expansive growth prospects across the forecast period of 2019-2027. Photopheresis is a type of medical treatment that performs the function of isolating white blood cells through a device. The white cells then go through an 8-methoxy psoralen treatment before the patient receives the blood.

  • The rising awareness about organ transplantation and the expanding prevalence of autoimmune diseases will bring immense growth opportunities for the photopheresis products market during the assessment period. The World Health Organization (WHO) estimates that nearly 100,800 solid organ transplants are carried out every year. These figures state the growing popularity of organ transplants, which brings immense growth prospects for the photopheresis products market.
  • The growing geriatric population numbers across the globe have led to an increase in the demand for photopheresis products considerably. This aspect will add extra stars of growth to the photopheresis products market.
  • The escalating focus of the government bodies of numerous countries on the healthcare infrastructure will sow the seeds of growth across the photopheresis products market. The high incidences of viral infections and chronic diseases have prompted many countries to focus intensively on ramping up the healthcare infrastructure. This factor bodes well for the growth of the photopheresis products market.
  • Research and development activities play a vital role in the growth of the photopheresis products market. The players invest substantially in these activities to gain insights. These activities help in the discovery of insights that help in enhancing or adding formulations to the products, ultimately helping in increasing the growth rate of the photopheresis products market.
  • Strategic collaborations are an important part of the growth trajectory of the photopheresis products market. Mergers, acquisitions, partnerships, and joint ventures are vital for the overall development of the photopheresis products market. The players indulge in these activities for cementing their stronghold over the photopheresis products market. These factors eventually contribute to the growth structure of the photopheresis products market.
  • The COVID-19 pandemic has caused distress across many sectors and businesses. The photopheresis products market is no exception. With the advent of the pandemic, many countries sealed their borders and enforced strict lockdown restrictions. All the economic activities and the movement of people came to a halt all of a sudden. It had a massive impact on the photopheresis products market. Even if photopheresis products were exempted from the lockdown restrictions, supply chain and logistics disruptions were reported, which caused great losses.

Global Photopheresis Products Market: Overview

Photopheresis is a type of photodynamic therapy solution wherein blood is treated with blood sensitizing agents. These blood sensitizing agents are then subjected to irradiation with specific light wavelengths. Products in the global photopheresis products market are witnessing increased demand owing to rising prevalence of various autoimmune diseases along with rising instances of organ transplant surgical cases. Other drivers for the global photopheresis products market include rising global healthcare infrastructures, increase in the geriatric population across the globe, and enhancements in medical technologies. Growing number of private healthcare insurance players along with supportive government reimbursement policies is also expected to thrust growth in the global photopheresis products market in coming years.

Additional motivators for the global photopheresis products market include faster approval timing required by regulatory bodies and rising adoption of the devices offered by the vendors and manufacturers in the global photopheresis products market. However, lack of awareness and resulting low penetration of extra corporeal photopheresis or ECP therapy centers can restrict the growth of the global photopheresis products market in the near future. Manufacturers and players in the global photopheresis products market are investing in advanced technologies to come up with faster and more efficient devices to be used in extra corporeal photopheresis or ECP therapy solutions. This trend is anticipated to favor the growth trajectory of the global photopheresis products market in coming years.

Global Photopheresis Products Market - Segmentation

Product Type
  • Open ECP System
  • Closed ECP System

Application
  • Cutaneous T-cell lymphoma
  • Graft versus host disease
  • Transplant rejections
  • Autoimmune diseases

End-user
  • Hospitals
  • Specialty Clinics

Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America

Frequently Asked Questions

What is the total market worth of photopheresis products market?

The global photopheresis products market was worth US$ 262.4 Mn and is projected to reach a value of US$ 423.2 Mn by the end of 2027

What is the anticipated CAGR of the photopheresis products market in the forecast period?

Photopheresis products market is anticipated to grow at a CAGR of 5.3% during the forecast period

Which region is expected to project the highest market share in the global photopheresis products market?

North America accounted for a major share of the global photopheresis products market

What are the key driving factors for the growth of the photopheresis products market?

Global photopheresis products market is driven by increase in increase in organ transplantations, increase in cutaneous T-cell lymphoma and favorable reimbursement policies

Who are the key players in the global photopheresis products market?

Key players in the global photopheresis products market include Macopharma, Med Tech Solutions GmbH, Haemonetics Corporation, Fresenius Kabi AG, Terumo Corporation, and Mallinckrodt Pharmaceuticals

    1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Photopheresis Market

    4. Market Overview

    4.1. Introduction

    4.1.1. By Product Definition

    4.1.2. Industry Evolution / Developments

    4.2.  Overview

    4.3. Key Market Indicators

    4.3.1. Region/Country Specific

    4.3.2. Product/Application/Therapeutic Area Specific

    4.3.3. Target Market Specific – Global Scenario

    4.4. Market Dynamics

    4.4.1. Drivers

    4.4.2. Restraints

    4.4.3. Opportunity

    4.4.Global Photopheresis Products Market Forecast, 2018-2027

    4.4.1.Market Size Forecast

    4.4.2.Pipeline Analysis

    4.5.Organ and Stem Cell Transplantations Overview

    4.6.Photopheresis Therapy Snapshot

    4.7. Global Photopheresis Market Analysis and Forecasts, 2018-2027

    4.7.1. Market Revenue Projections (US$ Mn)

    4.8. Photopheresis Market - Global Supply Demand Scenario

    4.9. Porter’s Five Force Analysis

    4.10. Market Outlook

    5. Global Photopheresis Market Analysis and Forecasts, By Product

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Key Trends

    5.4. Market value  Forecast By Product, 2018-2027

    5.4.1. Open ECP system

    5.4.2. Closed ECP system

    5.5. By Product Comparison Matrix

    5.6. Market Attractiveness By Product

    6. Global Photopheresis Market Analysis and Forecasts, By End User

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Key Trends

    6.4. Market value  Forecast By End User, 2018-2027

    6.4.1. Hospitals

    6.4.2. Specialty Clinics

    6.5. End User  Comparison Matrix

    6.6. Market Attractiveness By End User

    7. Global Photopheresis Market Analysis and Forecasts, By Therapeutic Area

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Key Trends

    7.4. Market value  Forecast By Therapeutic Area, 2018-2027

    7.4.1. Cutaneous T-cell Lymphoma

    7.4.2. Graft-versus-Host Disease

    7.4.3. Transplantation rejection

    7.4.4. Autoimmune Disease

    7.5. Therapeutic Area  Comparison Matrix

    7.6. Market Attractiveness By Therapeutic Area

    8. Global Photopheresis Market Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Policies and Regulations

    8.3. Market value  Forecast By Region

    8.3.1. North America

    8.3.2. Latin America

    8.3.3. APAC

    8.3.4. Europe

    8.3.5. MEA

    8.4. Market Attractiveness By Country/Region

    9. North America Photopheresis Market Analysis and Forecast

    9.1. Introduction

    9.1.1. Key Findings

    9.1.2. Policies and Regulations

    9.1.3. Price Trend Analysis

    9.1.4. Key Trends

    9.2. Market value  Forecast By Product, 2018-2027

    9.2.1. Open ECP system

    9.2.2. Closed ECP system

    9.3. Market value  Forecast By End User, 2018-2027

    9.3.1. Hospitals

    9.3.2. Specialty Clinics

    9.4. Market value  Forecast By Therapeutic Area, 2018-2027

    9.4.1. Cutaneous T-cell Lymphoma

    9.4.2. Graft-versus-Host Disease

    9.4.3. Transplantation rejection

    9.4.4. Autoimmune Disease

    9.5. Market value  Forecast By Country, 2018-2027

    9.5.1. US

    9.5.2. Canada

    9.6. Market Attractiveness Analysis

    9.6.1. By Product

    9.6.2. By End User

    9.6.3. By Therapeutic Area

    9.6.4. By Country

    10. Latin America Photopheresis Market Analysis and Forecast

    10.1.Introduction

    10.1.1. Key Findings

    10.1.2. Policies and Regulations

    10.1.3. Price Trend Analysis

    10.1.4. Key Trends

    10.2.Market value  Forecast By Product, 2018-2027

    10.2.1. Open ECP system

    10.2.2. Closed ECP system

    10.3.Market value  Forecast By End User, 2018-2027

    10.3.1. Hospitals

    10.3.2. Specialty Clinics

    10.4.Market value  Forecast By Therapeutic Area, 2018-2027

    10.4.1. Cutaneous T-cell Lymphoma

    10.4.2. Graft-versus-Host Disease

    10.4.3. Transplantation rejection

    10.4.4. Autoimmune Disease

    10.5.Market value  Forecast By Country, 2018-2027

    10.5.1. Brazil

    10.5.2. Mexico

    10.5.3. Rest of Latin America

    10.6.Market Attractiveness Analysis

    10.6.1. By Product

    10.6.2. By End User

    10.6.3. By Therapeutic Area

    10.6.4. By Country

    11. APAC Photopheresis Market Analysis and Forecast

    11.1.Introduction

    11.1.1. Key Findings

    11.1.2. Policies and Regulations

    11.1.3. Price Trend Analysis

    11.1.4. Key Trends

    11.2.Market value  Forecast By Product, 2018-2027

    11.2.1. Open ECP system

    11.2.2. Closed ECP system

    11.3.Market value  Forecast By End User, 2018-2027

    11.3.1. Hospitals

    11.3.2. Specialty Clinics

    11.4.Market value  Forecast By Therapeutic Area, 2018-2027

    11.4.1. Cutaneous T-cell Lymphoma

    11.4.2. Graft-versus-Host Disease

    11.4.3. Transplantation rejection

    11.4.4. Autoimmune Disease

    11.5.Market value  Forecast By Country, 2018-2027

    11.5.1. Japan

    11.5.2. India

    11.5.3. China

    11.5.4. Rest of APAC

    11.6.Market Attractiveness Analysis

    11.6.1. By Product

    11.6.2. By End User

    11.6.3. By Therapeutic Area

    11.6.4. By Country

    12. Europe Photopheresis Market Analysis and Forecast

    12.1.Introduction

    12.1.1. Key Findings

    12.1.2. Policies and Regulations

    12.1.3. Price Trend Analysis

    12.1.4. Key Trends

    12.2.Market value  Forecast By Product, 2018-2027

    12.2.1. Open ECP system

    12.2.2. Closed ECP system

    12.3.Market value  Forecast By End User, 2018-2027

    12.3.1. Hospitals

    12.3.2. Specialty Clinics

    12.4.Market value  Forecast By Therapeutic Area, 2018-2027

    12.4.1. Cutaneous T-cell Lymphoma

    12.4.2. Graft-versus-Host Disease

    12.4.3. Transplantation rejection

    12.4.4. Autoimmune Disease

    12.5.Market value  Forecast By Country, 2018-2027

    12.5.1. UK

    12.5.2. France

    12.5.3. Germany

    12.5.4. Spain

    12.5.5. Italy

    12.5.6. Russia

    12.5.7. Rest of Europe

    12.6.Market Attractiveness Analysis

    12.6.1. By Product

    12.6.2. By End User

    12.6.3. By Therapeutic Area

    12.6.4. By Country

    13. MEA Photopheresis Market Analysis and Forecast

    13.1.Introduction

    13.1.1. Key Findings

    13.1.2. Policies and Regulations

    13.1.3. Price Trend Analysis

    13.1.4. Key Trends

    13.2.Market value  Forecast By Product, 2018-2027

    13.2.1. Open ECP system

    13.2.2. Closed ECP system

    13.3.Market value  Forecast By End User, 2018-2027

    13.3.1. Hospitals

    13.3.2. Specialty Clinics

    13.4.Market value  Forecast By Therapeutic Area, 2018-2027

    13.4.1. Cutaneous T-cell Lymphoma

    13.4.2. Graft-versus-Host Disease

    13.4.3. Transplantation rejection

    13.4.4. Autoimmune Disease

    13.5.Market value  Forecast By Country, 2018-2027

    13.5.1. South Africa

    13.5.2. Saudi Arabia

    13.5.3. UAE

    13.5.4. Rest of MEA

    13.6.Market Attractiveness Analysis

    13.6.1. By Product

    13.6.2. By End User

    13.6.3. By Therapeutic Area

    13.6.4. By Country

    14. Competition Landscape

    14.1.Market Player – Competition Matrix (By Tier and Size of companies)

    14.2.Market Share Analysis By Company (2019)

    14.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

    14.3.1. Haemonetics Corporation

            14.3.1.1.Company Overview

            14.3.1.2.Financial Overview

            14.3.1.3.Product Portfolio

            14.3.1.4.Business Strategies

            14.3.1.5.Recent Developments

    14.3.2. Fresenius Kabi AG

            14.3.2.1.Company Overview

            14.3.2.2.Financial Overview

            14.3.2.3.Product Portfolio

            14.3.2.4.Business Strategies

            14.3.2.5.Recent Developments

    14.3.3. Macopharma

            14.3.3.1.Company Overview

            14.3.3.2.Financial Overview

            14.3.3.3.Product Portfolio

            14.3.3.4.Business Strategies

            14.3.3.5.Recent Developments

    14.3.4. Terumo Corporation

            14.3.4.1.Company Overview

            14.3.4.2.Financial Overview

            14.3.4.3.Product Portfolio

            14.3.4.4.Business Strategies

            14.3.4.5.Recent Developments

    14.3.5. Med Tech Solutions GmbH

            14.3.5.1.Company Overview

            14.3.5.2.Financial Overview

            14.3.5.3.Product Portfolio

            14.3.5.4.Business Strategies

            14.3.5.5.Recent Developments

    14.3.6. Mallinckrodt Pharmaceuticals

            14.3.6.1.Company Overview

            14.3.6.2.Financial Overview

            14.3.6.3.Product Portfolio

            14.3.6.4.Business Strategies

            14.3.6.5.Recent Developments

    List of Tables

    Table 01.Global Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2018–2027

    Table 02.Global Photopheresis Products Market Size (US$ Mn), by Therapeutic Area, 2018–2027

    Table 03.Global Photopheresis Products Market Size (US$ Mn) Forecast, by End User, 2018–2027

    Table 04.Global Photopheresis Products Market Size (US$ Mn) Forecast, by Region, 2018–2027

    Table 05.North America Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2018–2027

    Table 06.North America Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2018–2027

    Table 07.North America Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2018–2027

    Table 08.North America Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2018–2027

    Table 09.Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2018–2027

    Table 10.Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2018–2027

    Table 11.Europe Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2018–2027

    Table 12.Europe Photopheresis Products Market Size (US$ Mn) Forecast, by Country, 2018-2027

    Table 13.Latin America Photopheresis Products Market Size (US$ Mn) Forecast, By Product Type, 2018–2027

    Table 14.Latin America Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2018–2027

    Table 15.Latin America Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2018–2027

    Table 16.Latin America Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2018–2027

    Table 17.Asia Pacific Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2018–2027

    Table 18.Asia Pacific Photopheresis Products Market Size (US$ Mn) Forecast, By Therapeutic Area, 2018–2027

    Table 19.Asia Pacific Photopheresis Products Market Size(US$ Mn) Forecast, by Product Type, 2018–2027

    Table 20.Asia Pacific Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2018–2027

    Table 21.Middle East & Africa Photopheresis Products Market Size (US$ Mn) Forecast, by Product Type, 2018–2027

    Table 22.Middle East & Africa Photopheresis Products Market Size (US$ Mn) Forecast, by Therapeutic Area, 2018-2027

    Table 23.Middle East & Africa Photopheresis Products Market Size(US$ Mn) Forecast, by End User, 2018-2027

    Table 24.Middle East & Africa Photopheresis Products Market Size(US$ Mn) Forecast, by Country, 2018–2027

    List of Figures

    Figure 01:Global Photopheresis Products Market Size (US$ Mn) Forecast, 2018–2027

    Figure 02:Clinical Trials Conducted,

    Figure 03:No. of Clinical Trials Carried Out

    Figure 04:No. of Clinical Trials in Different Phases

    Figure 05:No. of Clinical Trials on Disease Indication

    Figure 06:Global Organ Transplantations, by Region (%), (2019)

    Figure 07:Global Organ Transplantations Volume

    Figure 08:Global Lung Transplantations, by Region (%), (2019)

    Figure 09:Global Lung Transplantations Volume

    Figure 10:Global Liver Transplantations, by Region (%), (2019)

    Figure 11:Global Liver Transplantations Volume

    Figure 12:Global Kidney Transplantations, by Region (%), (2019)

    Figure 13:Global Kidney Transplantation Volume

    Figure 14:Global Stem Cell Transplants, by Type

    Figure 15:Global Stem Cell Transplants Volume

    Figure 16:Global Stem Cell Transplants, by Region (%) (2019)

    Figure 17:Regional Stem Cell Transplants Volume

    Figure 18:Global Photopheresis Products  Market Value Share By Product (2016)

    Figure 19:Global Photopheresis Products  Market Value Share By Therapeutic Area (2016)

    Figure 20:Global Photopheresis Products  Market Value Share By Region (2016)

    Figure 21:Global Photopheresis Products  Market Value Share By End User (2016)

    Figure 22:Global Photopheresis Products Market Value Share Analysis, by Product Type, 2019 and 2027

    Figure 23:Photopheresis Products Market Attractiveness Analysis, by Product Type, 2020-2027

    Figure 24:Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Open System, 2018–2027

    Figure 25:Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Closed System, 2018–2027

    Figure 26:Global Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2019 and 2027

    Figure 27:Global Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2020-2027

    Figure 28:Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Cutaneous T-cell Lymphoma, 2018–2027

    Figure 29:Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Graft-versus-Host Disease, 2018–2027

    Figure 30:Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Transplant Rejections, 2018–2027

    Figure 31:Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Autoimmune Diseases, 2018–2027

    Figure 32:Global Photopheresis Products Market Value Share Analysis, by End User, 2019 and 2027

    Figure 33:Global Photopheresis Products Market Attractiveness Analysis, by End User, 2020-2027

    Figure 34:Global Photopheresis Products Market Revenue (US$ Mn) and

    Figure 35:Global Photopheresis Products Market Revenue (US$ Mn) and Y-o-Y growth (%), by Specialty Clinics, 2018–2027

    Figure 36:Global Photopheresis Products Market Value Share Analysis, by Region, 2019 and 2027

    Figure 37:Photopheresis Products Market Attractiveness Analysis, by Region

    Figure 38:North America Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y, 2018–2027

    Figure 39:North America Photopheresis Products Market Attractiveness Analysis, by Country,2020-2027

    Figure 40:North America Photopheresis Products Market Value Share Analysis, by Product Type, 2019 and 2027

    Figure 41:North America Photopheresis Products Market Attractiveness Analysis, by Product Type, 2020-2027

    Figure 42:North America Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2019 and 2027

    Figure 43:North America Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area

    Figure 44:North America Photopheresis Products Market Value Share Analysis, by End User, 2019 and 2027

    Figure 45:North America Photopheresis Products Market Attractiveness Analysis, by End User, 2020-2027

    Figure 46:Europe Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y 2018–2027

    Figure 47:Europe Photopheresis Products Market Attractiveness Analysis, by Country, 2018–2027

    Figure 48:Europe Photopheresis Products Market Value Share Analysis, by Product Type, 2019 and 2027

    Figure 49:Europe Photopheresis Products Market Attractiveness Analysis, by Product Type, 2020-2027

    Figure 50:Europe Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2019 and 2027

    Figure 51:Europe Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2020-2027

    Figure 52:Europe Photopheresis Products Market Value Share Analysis, by End User, 2019 and 2027

    Figure 53:Photopheresis Products Market Attractiveness Analysis, by End User, 2020-2027

    Figure 54:Latin America Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y , 2018–2027

    Figure 55:Latin America Photopheresis Products Market Attractiveness Analysis, by Region ,2020-2027

    Figure 56:Latin America Photopheresis Products Market Value Share Analysis by Product Type, 2019 and 2027

    Figure 57:Latin America Photopheresis Products Market Attractiveness Analysis, by Product Type,2020-2027

    Figure 58:Latin America Photopheresis Products Market Value Share Analysis By Therapeutic Area, 2019 and 2027

    Figure 59:Latin America Photopheresis Products Market Attractiveness Analysis by Therapeutic Area, 2020-2027

    Figure 60:Latin America Photopheresis Products Market Value Share Analysis by End User, 2019 and 2027

    Figure 61:Latin America  Photopheresis Products Market Attractiveness Analysis by End User, 2020-2027

    Figure 62:Asia Pacific Photopheresis Products Forecast Market Size (US$ Mn) and Y-o-Y, 2018–2027

    Figure 63:Asia Pacific Photopheresis Products Market Attractiveness Analysis, by Region, 2020-2027

    Figure 64:Asia Pacific Photopheresis Products Market Value Share Analysis by Product Type, 2019 and 2027

    Figure 65:Asia Pacific Photopheresis Products Market Attractiveness Analysis, by Product Type, 2020-2027

    Figure 66:Asia Pacific Photopheresis Products Market Value Share Analysis by Therapeutic Area, 2019 and 2027

    Figure 67:Asia Pacific Photopheresis Products Market Attractiveness Analysis, By  Therapeutic Area, 2020-2027

    Figure 68:Asia Pacific Photopheresis Products Market Value Share Analysis by End User, 2019 and 2027

    Figure 69:Asia Pacific Photopheresis Products Market Attractiveness Analysis, by End User, 2020-2027

    Figure 70:Middle East & Africa Photopheresis Products Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2027

    Figure 71:Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Country, 2020-2027

    Figure 72:Middle East & Africa Photopheresis Products Market Value Share Analysis, by Product Type, 2019 and 2027

    Figure 73:Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Product Type, 2020-2027

    Figure 74:Middle East & Africa Photopheresis Products Market Value Share Analysis, by Therapeutic Area, 2019 and 2027

    Figure 75:Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by Therapeutic Area, 2020-2027

    Figure 76:Middle East & Africa Photopheresis Products Market Value Share Analysis, by End User, 2019 and 2027

    Figure 77:Middle East & Africa Photopheresis Products Market Attractiveness Analysis, by End User, 2020-2027

    Figure 78:Photopheresis Products Market Share Analysis, by Company (2019)

Copyright © Transparency Market Research, Inc. All Rights reserved

Photopheresis Products Market

Schedule a Call